Hemodialysis and Peritoneal Dialysis Market Valued at USD 103.8 Million in 2023

Trishita Deb
Trishita Deb

Updated · Mar 14, 2025

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Overview

New York, NY – March 14, 2025 –  Global Hemodialysis and Peritoneal Dialysis Market size is expected to be worth around USD 226.3 Million by 2033 from USD 103.8 Million in 2023, growing at a CAGR of 8.1% during the forecast period from 2024 to 2033.

Hemodialysis is a procedure that removes waste products and excess fluids from the blood using a dialysis machine. This method is commonly performed in specialized clinics or hospitals. Conversely, peritoneal dialysis offers a home-based alternative where the peritoneum acts as a natural filter, reducing dependency on clinical visits.

Increasing awareness about advanced dialysis options, coupled with technological advancements such as portable dialysis devices, is enhancing patient convenience and boosting market growth. North America currently dominates the market due to improved healthcare infrastructure and higher adoption rates of dialysis treatments. Meanwhile, the Asia-Pacific region is anticipated to witness significant growth, driven by rising CKD incidences and improved access to healthcare services.

Key industry players are focusing on innovative product launches and strategic collaborations to strengthen their market presence and meet the growing demand for dialysis solutions.

Hemodialysis and Peritoneal Dialysis Market Size

Key Takeaways

  • Market Size: The Hemodialysis and Peritoneal Dialysis Market is projected to reach approximately USD 226.3 million by 2033, rising from USD 103.8 million in 2023.
  • Market Growth: The market is anticipated to expand at a compound annual growth rate (CAGR) of 8.1% between 2024 and 2033.
  • Type Analysis: The hemodialysis segment emerged as the market leader in 2023, accounting for over 83.8% of the total revenue share.
  • Product Analysis: The services segment held the largest market share in 2023, contributing more than 57.1% of total revenue.
  • End-Use Analysis: The hospital-based segment dominated the market in 2023, representing 77% of the total market share.
  • Regional Analysis: North America led the global market in 2023, holding a revenue share exceeding 38%.

Segmentation Analysis

  • Type Analysis: The hemodialysis segment held the largest revenue share of over 83.8% in 2023 and is projected to continue growing steadily. This segment includes short-term hemodialysis (conventional) and nocturnal dialysis. Peritoneal dialysis is categorized into Ambulatory Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD), driven by rising ESRD cases, an aging population, and increasing incidences of diabetes and hypertension. The World Population Ageing 2020 report forecasts 1.4 billion elderly individuals by 2050, further fueling segment growth.
  • Product Analysis: The service segment dominated the market in 2023 with over 57.1% share, driven by rising ESRD cases and expanding dialysis service centers worldwide. Technological advancements, such as DaVita Care Connect’s telehealth integration in 2021, further contribute to growth. The consumables market, projected to grow at a 5.8% CAGR, benefits from innovations like antimicrobial-coated catheters that reduce bloodstream infections. Companies are developing advanced materials and dialyzers with improved membrane designs, enhancing patient safety and treatment efficacy.
  • End-Use Analysis: The hospital-based segment accounted for over 77% of the market in 2023, supported by skilled staff and high-quality care standards. Growth is further driven by dedicated dialysis centers and customized hemodialysis machines. The home-based segment is expected to grow at a 6.6% CAGR, driven by improved patient convenience, reduced travel costs, and growing adoption among elderly individuals with renal issues seeking flexible dialysis options.

Market Segments

Type

  • Hemodialysis
  • Conventional hemodialysis
  • Short daily hemodialysis
  • Nocturnal hemodialysis
  • Peritoneal dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Product

Device

  • Machine
  • Dialyzer
  • Water treatment system
  • Others

Consumables

  • Bloodline
  • Concentrates
  • Catheters
  • Others

Services

End-user

  • Home-based
  • Hospital-based

Market Dynamics

  • Driver: The increasing prevalence of end-stage kidney disease (ESKD) significantly drives the demand for hemodialysis and peritoneal dialysis treatments. Globally, over 2 million individuals require dialysis, with numbers expected to rise due to factors like diabetes and hypertension. This escalating patient population necessitates accessible and effective dialysis options. Additionally, initiatives such as the Advancing American Kidney Health Initiative aim to enhance home dialysis usage, further propelling market growth
  • Trend: A notable trend in dialysis care is the shift towards home-based therapies, including peritoneal dialysis and home hemodialysis. This transition offers patients greater flexibility and quality of life. Technological advancements have facilitated the development of user-friendly dialysis equipment suitable for home use. Moreover, policy initiatives encourage increased adoption of home dialysis modalities, reflecting a broader movement towards patient-centered care.
  • Restraint: Economic challenges hinder the widespread adoption of peritoneal dialysis. Despite its cost-effectiveness from a payer’s perspective, financial barriers exist for patients, caregivers, and providers. Misaligned economic incentives and underappreciated costs contribute to these challenges, limiting peritoneal dialysis utilization. Addressing these financial obstacles is crucial to promote equitable access to diverse dialysis options.
  • Opportunity: Advancements in dialysis membrane technology present significant opportunities to improve treatment efficacy and patient outcomes. Enhanced membrane designs can more effectively remove toxins during dialysis sessions, leading to better clinical results. Investing in research and development of innovative dialysis membranes offers potential for improved patient care and market expansion.

Regional Analysis

North America held a dominant position in the market, accounting for over 38% of the revenue share in 2023. This growth can be attributed to the presence of leading industry players, substantial government investments in innovative medical device development, and a favorable reimbursement framework. Additionally, the increasing prevalence of kidney diseases and chronic kidney conditions (CKD) is driving the demand for dialysis treatments.

Further contributing to market expansion are factors such as increased healthcare spending, proactive government initiatives, and higher disposable incomes.

Meanwhile, the Asia Pacific region is projected to witness the highest compound annual growth rate (CAGR) of 5.6% during the forecast period. This growth will be fueled by the rising incidence of kidney diseases, an expanding elderly population, and advancements in product innovation. According to the International Diabetes Federation (IDF), Southeast Asia had approximately 88 million individuals living with diabetes in 2023, with this figure expected to reach 153 million by 2045.

Additional growth drivers in the region include increased healthcare spending, government-led initiatives, awareness campaigns addressing CKD, the availability of advanced medical technologies, and the establishment of modern healthcare facilities.

Emerging Trends

  • Development of Artificial Kidneys: Innovations are underway to create implantable bioartificial kidneys. These devices aim to mimic natural kidney functions, potentially reducing the need for traditional dialysis methods.
  • Wearable Dialysis Devices: Research is focused on wearable artificial kidneys that allow continuous blood filtration, offering patients greater mobility and lifestyle flexibility compared to conventional in-center treatments.
  • Advancements in Continuous Renal Replacement Therapy (CRRT): The integration of information technology and precision medicine into CRRT has led to personalized treatment approaches, enhancing patient outcomes.
  • Supply Chain Resilience: Recent natural disasters have highlighted the importance of robust supply chains. For instance, Baxter International aims to restore peritoneal dialysis solution availability to pre-Hurricane Helene levels by the end of the year, ensuring uninterrupted patient care.
  • Enhanced Vascular Access Monitoring: Innovations like EchoMark, an ultrasound-visible marker, have been developed to improve the monitoring of arteriovenous fistulas in hemodialysis patients. This advancement aims to reduce reliance on central venous catheters, thereby decreasing the risk of bloodstream infections.

Use Cases

  • Hemodialysis: This treatment is typically administered in specialized centers three times per week, with each session lasting approximately four hours. In 2011, hemodialysis was among the most common procedures in U.S. hospitals, accounting for 909,000 hospital stays, equating to a rate of 29 stays per 10,000 population.
  • Peritoneal Dialysis: This method allows patients to manage their treatment at home, performing exchanges 4–5 times daily. Automatic systems can facilitate more frequent cycles overnight. While peritoneal dialysis is less efficient per session than hemodialysis, its continuous nature yields comparable overall efficacy in waste removal.

Conclusion

The Hemodialysis and Peritoneal Dialysis market is poised for significant growth, driven by rising cases of chronic kidney diseases (CKD) and advancements in dialysis technology. The market’s projected expansion at a CAGR of 8.1% reflects increasing adoption rates of both clinical and home-based dialysis treatments. Innovations such as wearable dialysis devices and bioartificial kidneys are set to improve patient outcomes and convenience.

While North America dominates the sector due to robust healthcare infrastructure, the Asia Pacific region is anticipated to witness rapid growth owing to improved healthcare access and rising CKD incidences. Addressing economic barriers, enhancing product development, and strengthening supply chain resilience will be crucial in sustaining market growth and ensuring widespread access to effective dialysis solutions.

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Latest from the featured industries
Request a Sample Report
We'll get back to you as quickly as possible